Alzheimer's disease detection

Cognito's neuromodulation device
Neurotechnology company Cognito Therapeutics scores $73M
By Jessica Hagen | 10:52 am | March 23, 2023
The company will use the funds to advance the study of its neuromodulation device intended to treat Alzheimer's disease.
Detailed atrophy patterns that AI focused on predicting the progression to Alzheimer's disease
Fujifilm develops AI tech for predicting Alzheimer's progression
By Adam Ang | 11:36 pm | April 18, 2022
A clinical trial has shown that it can predict AD progression with 88% and 84% accuracy in American and Japanese patients, respectively.